Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/1993
09/09/1993DE4206850A1 Absorbent compsn. used in packaging, soil improvement, cable jackets and hygiene prods. - contains water soluble or swellable polysaccharide deriv., water swellable synthetic polymer, soft matrix, crosslinker and antiblocking agent
09/08/1993EP0559502A1 Topical care composition containing lipidic vesicles encapsulating at least one mineral water
09/08/1993EP0559463A1 Pharmaceutical coated cores
09/08/1993EP0559450A2 Binder and its uses
09/08/1993EP0559411A1 Titratable transdermal patch system and method for administration of therapeutic substances
09/08/1993EP0559320A2 Water-in-oil emulsions
09/08/1993EP0559319A2 Oil-in-water emulsions
09/08/1993EP0559013A1 Liquid or pasty storage-stable multiple emulsion of the O/W/O type
09/08/1993EP0558913A1 Improved pulsatile once-a-day delivery systems for minocycline
09/08/1993EP0558779A1 Compositions containing ranitidine/bismuth carboxylates salts
09/08/1993EP0558750A1 Dispersion preparation
09/08/1993EP0558697A1 Localized oligonucleotide therapy
09/08/1993EP0558645A1 Erythrocytes and thrombo-erythrocytes as target specific agents
09/08/1993EP0558586A1 A gel-forming liquid carrier composition.
09/08/1993EP0558571A1 Method of making oil filled paucilamellar lipid vesicles.
09/08/1993EP0553194A4 Effective solid non-lozenge anti-acid/anti-gas medicament
09/08/1993EP0533763A4 Fractionated agaroid compositions, their preparation, and use
09/08/1993EP0486563B1 Chewing gum composition with accelerated, controlled release of active agents
09/08/1993EP0449960B1 Heat-dehydrated emulsion compositions
09/08/1993EP0441833B1 Dosage form having reduced abuse potential
09/08/1993EP0437523B1 Triglycerides, nutritional composition comprising such triglycerides, and use of the nutritional composition for nutrition
09/08/1993CN1075887A Method for preparing "kuhuang" injection
09/08/1993CN1075877A Method for preparing moistening wound and burn ointment
09/08/1993CN1075871A Method for preparing long-acting slow-releasing medicine capsule
09/08/1993CN1022024C Vitamine-containing granules and production method thereof
09/08/1993CN1022023C Process for liquid pharmaceutical composition containing piperidinoalkanol derivatives
09/07/1993USH1228 Concentric spheres, inner one containing medicine
09/07/1993US5243044 Synthetic blood
09/07/1993US5243035 Sialic acid-containing glycolipid derivatives
09/07/1993US5242951 Estrogen-containing gel preparation
09/07/1993US5242941 Administering melatonin to adjust sleep cycle of humans
09/07/1993US5242937 Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors
09/07/1993US5242910 Sustained release compositions for treating periodontal disease
09/07/1993US5242691 Purified milk product from animal maintained in hyperimmunized state
09/07/1993US5242433 Packaging system with in-tandem applicator pads for topical drug delivery
09/07/1993US5242391 Urethral insert for treatment of erectile dysfunction
09/07/1993CA1321874C Reagents for magnetizing nonmagnetic materials
09/06/1993CA2090912A1 Pharmaceutical coated cores
09/05/1993CA2090598A1 Titratable transdermal patch system and method for administration of therapeutic substances
09/04/1993WO1993017702A1 Oral vaccine
09/04/1993CA2131442A1 Oral vaccine
09/02/1993WO1993017040A2 Cystic fibrosis transmembrane conductance regulator (cftr) protein
09/02/1993WO1993017037A1 Treatment of acute migraine or cluster headache attacks
09/02/1993WO1993016735A1 Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
09/02/1993WO1993016733A1 Topical composition containing hyaluronic acid and nsaids
09/02/1993WO1993016732A1 Formulations containing hyaluronic acid
09/02/1993WO1993016731A1 A pH SENSITIVE, REVERSIBLE GELLING, ERODIBLE DRUG DELIVERY SYSTEM
09/02/1993WO1993016714A1 Tissue irrigating solution
09/02/1993WO1993016711A1 Use of injectable biomaterials in the treatment of hemorrhoids
09/02/1993WO1993016707A1 Linseed mucilage
09/02/1993WO1993016691A1 New use of omega-3-fatty acids
09/02/1993WO1993016690A1 Cytoprotective compositions containing pyruvate and antioxidants
09/02/1993WO1993016689A1 Pharmaceutical composition for use as a pain killer and containing (benzoyl-3 phenyl)-2 propionic-(r) acid
09/02/1993WO1993016687A1 Gels for encapsulation of biological materials
09/02/1993WO1993016686A1 Pharmaceutical preparation for sustained release of a drug and process for producing the same
09/02/1993CA2131032A1 Use of aggregated proteins to prolong retention time of a therapeutic agent adjacent a targeted site such as a tumor
09/02/1993CA2130993A1 Use of injectable biomaterials in the treatment of hemorrhoids
09/02/1993CA2130350A1 Linseed mucilage
09/02/1993CA2129732A1 Cytoprotective compositions containing pyruvate and antioxidants
09/02/1993CA2117535A1 New use of omega-3-fatty acids
09/02/1993CA2117489A1 Tissue irrigating solution
09/01/1993EP0558213A1 Process for preparing neotrehalose, and its uses
09/01/1993EP0557670A1 Pellets containing minocyclin
09/01/1993EP0557595A2 Target component assay
09/01/1993EP0557512A1 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid.
09/01/1993EP0557489A1 Composition providing a lasting cosmetic and/or pharmaceutical treatment of the upper epidermal layers by topical application on the skin.
09/01/1993EP0557385A1 Topical compositions for transdermal delivery of produg derivatives of morphine
09/01/1993EP0456764B1 Fat emulsion for endotracheal application, its production and use
09/01/1993EP0335982B1 Gelatin composition
09/01/1993CN1075633A Liposomal piroxicam formulations
09/01/1993CN1075631A Drug with the effect of resisting and preventing tension and intelligence-promoting
08/1993
08/31/1993US5240995 Electrotransport adhesive
08/31/1993US5240963 Branched polyanhydrides
08/31/1993US5240932 Percutaneously absorbable compositions of morphine or analogous analgesics of morphine
08/31/1993US5240917 Suppression of thromboxane levels by percutaneous administration of aspirin
08/31/1993US5240713 Dual rate agent delivery device
08/31/1993US5240712 Therapeutic agents
08/31/1993US5240711 Transdermal therapeutic system comprising as active component buprenorphine
08/31/1993US5240662 Process for the preparation of solid pharmaceutical compositions
08/31/1993CA1321849C Adhesive compositions, controlled release compositions and transdermal drug delivery device
08/31/1993CA1321692C Method and apparatus for granulation and granulated product
08/29/1993CA2090084A1 Topical application composition containing lipidic vesicles encapsulating at least one mineral water
08/28/1993WO1993016684A1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films
08/28/1993CA2109195A1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films
08/26/1993CA2090282A1 Target component assay
08/26/1993CA2089241A1 Process for preparing neotrehalose, and its uses
08/25/1993WO1993016685A1 Bioartificial endocrine device
08/25/1993EP0557244A1 Dosage forms having prolonged active-ingredient release
08/25/1993EP0557065A1 Spheroid formulation
08/25/1993EP0557064A1 Modified release formulation
08/25/1993EP0556917A1 A process for the preparation of biologically active material-containing polymeric microcapsules
08/25/1993EP0556394A1 Lyophilized preparation and production thereof
08/25/1993EP0556392A1 Process for producing fat emulsion
08/25/1993EP0556256A1 Aerosol medicaments.
08/25/1993EP0556239A1 Aerosol containing medicaments.
08/25/1993EP0487603B1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it
08/25/1993EP0471718B1 Pharmaceutical composition with a paracetamol base
08/25/1993EP0391893B1 Porous microspheres for drug delivery and methods for making same
08/25/1993EP0345317B1 Microcrystalline matrix for administration of beneficial agent
08/25/1993EP0261181B1 Nifedipine combination preparation